BDBM753993 4-(4-((1R,5S)-8,8-difluoro-3-azabicyclo[3.2.1]octane-3-yl)-8-fluoro-2-((1-((3-fluoropyrrolidin-1)-yl)methyl)cyclopropyl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)naphthalen-2-ol::US20250206759, Example 26

SMILES Oc1cc(-c2ncc3c(N4CC5CCC(C4)C5(F)F)nc(OCC4(CN5CCC(F)C5)CC4)nc3c2F)c2ccccc2c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 753993   

TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Chengdu Hyperway Pharmaceuticals

US Patent
LigandPNGBDBM753993(4-(4-((1R,5S)-8,8-difluoro-3-azabicyclo[3.2.1]octa...)
Affinity DataIC50: 1.00E+3nMAssay Description:In a 384-well reaction plate (Corning, CLS4514), 0.1 microliter of the compound was added. After centrifugation, a mixture of 5 microliters of Tag2-K...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent